Skip to content

A Clinical Study on the Treatment of Diabetic Ulcers with Quyu Shengji Decoction

A Clinical Study on the Treatment of Diabetic Ulcers Using Quyu Shengji Formula

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000901
Enrollment
Unknown
Registered
2026-04-03
Start date
2019-03-27
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Ulcer

Interventions

Shengji Huayu Ointment Group:Apply Shengji Huayu ointment locally once daily for 4 weeks.
Lithospermic acid Group:Apply Lithospermic acid ointment locally once daily for a 4-week treatment period.
Danshensu sodium Group:Apply Danshensu sodium Cream locally once daily for a 4-week treatment period.
Vanillic acid group:Apply the Vanillic acid cream topically once daily for 4 weeks.
Control group/Standard treatment group:Topical application of recombinant bovine basic fibroblast growth factor (rb-bFGF) once daily for 4 weeks.

Sponsors

Yueyang Hospital of Intergrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-65 years, gender; (2) Wound maximum diameter > 2 cm, and ulcer duration = 4 weeks; (3) Wound severityWagner12; (4) Possess good compliance, sign the informed consent form, and voluntarily participate in the study.

Exclusion criteria

Exclusion criteria: (1) Patients with severe systemic infections, deep abscesses, osteomyelitis, or gangrene (Wagner grade 3 or higher); (2) Patients with severe primary underlying diseases or dysfunction of the heart, liver, kidneys, etc.; (3) Pregnant or breastfeeding women; (4) Wounds characterized as cancerous ulcers, tuberculous ulcers, or radiation ulcers; (5) Patients with other vascular or autoimmune skin diseases (e.g., allergic vasculitis, necrotizing fasciitis, Behçet's disease, etc.).

Design outcomes

Primary

MeasureTime frame
Complete Healing Rate;

Secondary

MeasureTime frame
Overall clinical efficacy rate;Wound complete healing time;The trend of the healing curve with a 75% reduction in wound area.;

Countries

China

Contacts

Public ContactKan Ze

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine

mjbubu@qq.com+8618018663707

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026